Global Biomarkers Market valued at USD 40.1 billion in 2019, and it is predictable to reach USD 101.2 billion by 2026, at a CAGR of 14.2 %, over the forecast period.
Published | 19 May 2020
Biomarkers are widely used in the
analysis and management of multiple diseases. Physiological levels of
biomarkers also change upon the administration of drugs. The study of numerous
biomarkers helps clinicians make meaningful choices about the analysis, disease
stage, therapy plan, and prognosis in patients.
The high occurrence of cancer is
inspiring research initiatives, motivating the development of the market.
Extensive research and technological advancements used for the development of
biomarker-based clinical diagnostics are predictable to be the key funders for
exchange. An increase in the global affliction of long-lasting diseases,
particularly cardiovascular, cancer, diabetes disorders due to an inactive
lifestyle, unhealthy diet, and lack of exercise, has been a significant factor
motivating the market growth. Increasing R&D fueling for pharma and biotech
companies, a growing number of CROs and low cost of clinical trials in emerging
countries, the high occurrence of cancer, and new edges for research. On the
other hand, high capital savings and low cost-benefit ratio poorly suited
regulatory and repayment systems, and technical issues related to sample group
and storage are the significant reasons confining the growth of this market.
The request for diagnostic markets is
growing. Where unoriginal diagnostic tools were focused on making accurate and
reliable results, today’s market request extends to new analysis with actual
and steady results. There are essential challenges in presenting accurate
results in the early stage of diseases, especially in the case of cancer.
Investigative biomarkers are negligible
or non-invasive tools. Biomarkers, combined with crucial imaging and data
management technologies, are meeting the market prospects; however, they have
setbacks too. Biomarkers are used in imaging technology to deliver precise
imaging of oncology tumors and other problems and remove the chance of energy
revelation during imaging through CT scan and MRI scan.
Increasing usage of biomarkers in cancer
treatment is driving the market growth.
Biomarkers are used in application areas such as companion diagnostics, personalized medicines, and other diagnostic areas, including drug discovery and growth and disease risk assessment. These growing diagnostic uses of biomarkers are predictable to drive market growth in the coming years. Companion diagnostics and biomarkers have become progressively pertinent in the practice of medicine, foremost to improved diagnosis, dealing, and monitoring across several disease areas. It can be used to recognize patients likely to reply well to certain drugs or cure options. These diagnostics are often used in combination with a specific drug.
Technological advancements have permitted the grouping of biomarkers with novel drugs for precise diagnosis and following cure options. For instance, biomarkers can be functional for the cure of several neurological diseases by stalking brain health and activity by examining biomolecules. Nascent developments, such as biomarker signatures, have augmented the treatment rate of nervous disorders resulting in early diagnosis, non-invasive testing, and rapid drug development.
Biomarkers Market: Competitive Landscape
America conquered the biomarkers market globally in 2018 and is likely to remain
leading over the forecast period as well. This local dominance can be
attributed to the regional occurrence of major pharmaceutical and biotechnology
companies, increasing adoption of the newest technologies, and recognized
healthcare infrastructure. The U.S. is the leading biomarker market in North
America, which is expected to list the highest CAGR in the years ahead.
The Asia Pacific
region is predictable to record high development in the biomarkers market
internationally in the years ahead. The rising frequencies of chronic diseases
like cancer, neurological disorders, and cardiovascular diseases, rising
support of the local governments for drug discovery and growth programs,
quickening biomarkers mindfulness for disease analysis, and large patient pool
are the major elements boosting the biomarkers market development in the Asia
Pacific. China, Japan, and India are forecast to be major funders to the Asia
Pacific biomarkers market in the future. The promising environment for clinical
trials in the Asia Pacific is likely to fuel the biomarkers market over the
of the leading players operating in the global biomarkers market are Qiagen
N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, PerkinElmer
Inc., Merck KGaA, Bio-Rad Laboratories, Abbott Laboratories, EKF Diagnostics,
Enzo Biochem Inc., Meso Scale Diagnostics, LLC, Signosis, and PerkinElmer Inc.
and other prominent players.
Do not miss the business opportunity of Global
Biomarkers Market. Consult our analyst, gain crucial insights, and facilitate
your business growth.
The in-depth analysis of the report provides
the growth potential, upcoming trends, and statistics of the Global Biomarkers Market
size & forecast. The report promises to provide state-of-the-art technology
of Global Biomarkers Market and industry insights, which help decision-makers
to make sound strategic decisions. Furthermore, the report also analyzes the
market drivers, challenges, and competitive analysis of the market.
- Global Biomarkers Market, By Product (Consumables, Service),Type (Safety, Efficacy, Validation), Disease Indication (Cancer, Cardiovascular Disorders), Application (Diagnostics Development, Drug Discovery and Development, Disease-Risk), By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2016-2026
Publish Date: June 2020
Relevant Press Releases
- Perlite Market is driven by the development in industrial and commercial construction activities coupled with increasing demand from horticulture and agriculture sectors
- Liquid Nitrogen Market projecting a CAGR of 5.58% during the forecast period, 2020-2026
- Argon Gas market expected to grow at a CAGR of 4.9% from 2020-2026
- Global Automotive Fleet Leasing Market Research Report - Forecast to 2025
- Consumer and SMB NAS Market is Expected to Grow at CAGR 9%